Literature DB >> 32662971

Ultrasound-Driven Biomimetic Nanosystem Suppresses Tumor Growth and Metastasis through Sonodynamic Therapy, CO Therapy, and Indoleamine 2,3-Dioxygenase Inhibition.

Da Zhang1,2,3, Ziguo Lin1,2,4, Youshi Zheng1,2, Jibin Song3, Juan Li3, Yongyi Zeng4, Xiaolong Liu1,2.   

Abstract

The rational design of nanoplatforms to bypass reticuloendothelial system (RES) clearance, enhance spatiotemporal controllability, and boost host immune responses to achieve synergized tumor-targeted therapeutic purpose is highly desired. Herein, a biomimetic nanosystem is developed for tumor-targeted in situ delivery of singlet oxygen (1O2) and carbon monoxide (CO) in response to exogenous stimulus ultrasound (US) and endogenous stimulus hydrogen peroxide (H2O2) in tumor microenvironment, respectively. Taking advantages of tumor homing and RES evasion abilities of the macrophage membrane coating, our designed nanosystem shows excellent accumulation at the tumor site and effective suppression of tumor growth through US/H2O2-generated 1O2 and CO to induce cell apoptosis and mitochondrial dysfunction. Furthermore, our nanosystem can induce significant tumor immunogenic death by 1O2/CO therapy, then can achieve effective immune responses and long-term immune memory through the combination of indoleamin 2,3-dioxygenase (IDO) signal blocking to effectively against tumor rechallenge and prevent lung metastasis. Taken together, the here-presented therapeutic strategy based on sonodynamic/CO therapy and IDO signaling inhibition might provide a promising perspective for synergistically treating cancer in future clinical translations.

Entities:  

Keywords:  biomimetic nanosystem; carbon monoxide; immunotherapy; indoleamine 2,3-dioxygenase; sonodynamic therapy

Mesh:

Substances:

Year:  2020        PMID: 32662971     DOI: 10.1021/acsnano.0c03833

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  7 in total

Review 1.  Recent advances in sonodynamic immunotherapy.

Authors:  Hui Wang; Guo-Qing Sui; Zhi-Xia Sun; Jia-Rui Du; Yang Wang; Zong-Hua Yue; Han-Yu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-13       Impact factor: 4.322

Review 2.  Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response.

Authors:  Zhengnan Yuan; Ladie Kimberly De La Cruz; Xiaoxiao Yang; Binghe Wang
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 3.  Sonodynamic therapy: Rapid progress and new opportunities for non-invasive tumor cell killing with sound.

Authors:  Katherine M Nowak; Mark R Schwartz; Victoria R Breza; Richard J Price
Journal:  Cancer Lett       Date:  2022-02-11       Impact factor: 9.756

4.  An intelligent responsive macrophage cell membrane-camouflaged mesoporous silicon nanorod drug delivery system for precise targeted therapy of tumors.

Authors:  Minghua Li; Xiaolong Gao; Chao Lin; Aijun Shen; Jing Luo; Qiongqiong Ji; Jiaqi Wu; Peijun Wang
Journal:  J Nanobiotechnology       Date:  2021-10-24       Impact factor: 10.435

5.  Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy.

Authors:  Jiong Li; Sijia Wang; Xinyi Lin; Yanbing Cao; Zhixiong Cai; Jing Wang; Zhenxi Zhang; Xiaolong Liu; Ming Wu; Cuiping Yao
Journal:  Nanomicro Lett       Date:  2022-02-05

Review 6.  Ultrasound and nanomaterial: an efficient pair to fight cancer.

Authors:  Edouard Alphandéry
Journal:  J Nanobiotechnology       Date:  2022-03-18       Impact factor: 10.435

7.  Remodeling Tumor-Associated Neutrophils to Enhance Dendritic Cell-Based HCC Neoantigen Nano-Vaccine Efficiency.

Authors:  Yunhao Wang; Qingfu Zhao; Binyu Zhao; Youshi Zheng; Qiuyu Zhuang; Naishun Liao; Peiyuan Wang; Zhixiong Cai; Da Zhang; Yongyi Zeng; Xiaolong Liu
Journal:  Adv Sci (Weinh)       Date:  2022-02-10       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.